Literature DB >> 6381880

Lymphocyte subsets in Heymann nephritis.

I K Cheng, S E Dorsch, B M Hall.   

Abstract

Altered ratios of T lymphocyte subsets have recently been reported in some forms of glomerulonephritis, including membranous glomerulonephritis. Heymann nephritis is a model of membranous glomerulonephritis that can be induced in susceptible strains of rat by a single subcutaneous injection of renal tubular antigen in Freund's complete adjuvant. Monoclonal antibodies were used to identify cytotoxic/suppressor and helper/inducer T cells in the blood, spleen, peripheral lymph nodes, and, where relevant, the lymph node draining the antigen injection site in susceptible and nonsusceptible rat strains before and after immunization with renal tubular antigen. A marked interstrain variation in the proportions of T lymphocyte subsets was found, but this did not segregate strains that are susceptible to Heymann nephritis induction from those that are resistant. Neither the development of Heymann nephritis in susceptible strains or immunization of resistant strains with renal tubular antigen was associated with any specific alteration in the T lymphocyte subpopulations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381880

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  3 in total

1.  Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.

Authors:  D D Branisteanu; P Leenaerts; B van Damme; R Bouillon
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

2.  Interstitial mononuclear cell infiltration in Heymann nephritis.

Authors:  C Grönhagen-Riska; E Honkanen; E von Willebrand; I Tikkanen; A Miettinen; H Holthöfer; T Törnroth
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Immunoregulation in Heymann nephritis. I. Cell marker studies.

Authors:  J Cornish; A Z Barabas; R Lannigan; J Rozing
Journal:  Br J Exp Pathol       Date:  1989-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.